Chronic Gout

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Chronic Gout trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 4 trials

RecruitingPhase 1

NCT07367971

Drug-Drug Interaction Study of ABP-671 in Gout Patients

This is a open-Label, Within-Subject Drug-Drug Interaction Study of ABP-671 Added to Stable Allopurinol Therapy in Gout Patients. Pharmacokinetic (PK) interacti…

United States20 participantsStarted 2026-01-23

Treatment: ABP-671 plus allopurinol

RecruitingNot Applicable

NCT03524222

Home Hospital for Suddenly Ill Adults

The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model hav…

United States3,000 participantsStarted 2018-01-18

Treatment: Home Hospitalization

RecruitingPhase 2

NCT07116746

Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

This study will assess the effect of AR882 and XOI co-administration on sUA lowering as well as reducing tophus burden in the population that has failed uricase…

United States25 participantsStarted 2025-12-03

Treatment: AR882 75 mg, XOI Low Dose

RecruitingNot Applicable

NCT06694012

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

The aim of this study is to investigate the relationship between body fat distribution measured by CT scan and related risk factors with the risk of incident me…

Japan2,000 participantsStarted 2024-11-01

All recent trials (56 shown)

CompletedPhase 4

NCT06229145

A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every…

The study consists of 24-week double-blind trial to evaluate the non-inferiority of the efficacy and safety of pegloticase Q4W with MTX versus pegloticase Q2W w…

United States262 participantsStarted 2024-03-18

Treatment: Pegloticase, Methotrexate

WithdrawnNot Applicable

NCT07493798

Serum Potassium Prediction Using Machine Learning and Single-lead ECG

This is a retrospective study drawing on data from the Brigham and Women's Hospital Home Hospital Program's Database. Sociodemographic and clinical data from a…

United States0Started 2021-03-20

Treatment: Potassium estimation algorithm

Chronic Gout

Trial phase breakdown

Trial status

Actively recruiting — 4 trials

Drug-Drug Interaction Study of ABP-671 in Gout Patients

Home Hospital for Suddenly Ill Adults

Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

All recent trials (56 shown)

A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every…

Serum Potassium Prediction Using Machine Learning and Single-lead ECG

Trial phase breakdown

Trial status

Actively recruiting — 4 trials

Drug-Drug Interaction Study of ABP-671 in Gout Patients

Home Hospital for Suddenly Ill Adults

Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

All recent trials (56 shown)

A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every…

Serum Potassium Prediction Using Machine Learning and Single-lead ECG

Prediction of Expected Length of Hospital Stay Using Machine Learning

Prediction of Patient Deterioration Using Machine Learning

Prediction of 30-Day Readmission Using Machine Learning

Digital Care for Holistic Health in Older Adults With Diabetes and Multimorbidity

Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation

A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy II

Hereditary Tubulointerstitial Nephritis

Rural Hospital-Level Care at Home for Acutely Ill Adults

Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects…

A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontr…

Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)

Vegetarian Diet and Chronic Degenerative Diseases

A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy Volunteers

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Developing A Gout Action Plan in Primary Care Setting in Singapore

Maintenance or Withdrawal of Urate Lowering Therapy According to Ultrasound Features in Gout Patients: a Randomised Cont…

Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)